YOLFTbeta
30

Shantou Institute of Ultrasonic Instrument Co., Ltd.

301602 · SHE · Healthcare / Medical Devices

13.96CNY-0.35 (-2.45%)

Price History

Full chart

Market Stats

Previous Close14.31
Open14.30
Day Range13.91 – 14.47
52-Week Range13.40 – 25.39
Volume1.99M
Market Cap6.29B
P/E (TTM)61.21
Forward P/E0.00
EPS0.24
Dividend Yield1.02%
50-Day Avg15.57
200-Day Avg17.45

About

Shantou Institute of Ultrasonic Instrument Co., Ltd. engages in the research and development, manufacture, and sale of medical imaging equipment and non-destructive testing equipment in China. The company offers color doppler ultrasound, SIUI MAI, B/W, veterinary, and X-ray imaging systems. It also offers non-destructive testing equipment, such as flaw detector, thickness gauge, and probes and accessories. The company was founded in 1982 and is based in Shantou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. De Lai Li
  • Employees737
  • HeadquartersNo.77, Jinsha Road, Shantou, China, 515000, China
  • Websitehttps://www.siui.com.cn

Leadership

  • Mr. De Lai LiChairman & GM · b. 1962
  • Mr. Xu Bin LinVice Chairman & Executive VP · b. 1974
  • Mr. Xiaobo ChenFinancial Director & Accounting Supervisor · b. 1960
  • Mr. William LiExecutive Deputy GM & Chief Engineer · b. 1981
  • Ms. Yan Na ZhengExecutive Deputy General Manager · b. 1974
  • Mr. Yi Han XuExecutive Vice President · b. 1965
  • Mr. Hong Wei LiuSecretary & Director · b. 1969
  • Mr. Liexiang FanDeputy General Manager · b. 1963
  • Mr. Yan Xiong YuDeputy GM & Manager of the Production Technology Department · b. 1978
  • Mr. Sheng Jie LinDeputy General Manager · b. 1966

Financials

Income Statement

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Total Revenue336.18M326.54M375.81M405.51M
Growth (%)--2.87%+15.09%+7.90%
Cost of Revenue108.57M101.00M109.79M115.38M
Gross Profit227.62M225.55M266.03M290.13M
Gross Margin67.71%69.07%70.79%71.55%
Operating Expense113.90M116.56M123.41M134.16M
Operating Income113.72M108.98M142.61M155.97M
Operating Margin33.83%33.37%37.95%38.46%
EBITDA127.90M121.55M153.03M167.45M
EBITDA Margin38.04%37.22%40.72%41.29%
Net Income127.06M115.43M145.58M148.92M
Net Income Margin37.80%35.35%38.74%36.72%
R&D42.88M47.72M50.04M50.14M
R&D as % of Total Revenue12.75%14.62%13.32%12.36%

Balance Sheet

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Total Assets746.49M839.42M1.01B1.49B
Total Liabilities139.36M115.66M135.38M126.87M
Total Equity607.85M723.77M870.66M1.36B
Cash443.37M387.35M707.77M1.17B

Cash Flow

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow130.66M73.42M132.39M135.25M
Capital Expenditure2.78M1.53M18.67M15.20M
Free Cash Flow127.87M71.88M113.73M120.05M
Dividends Paid36.41M--43.69M
FCF to OCF97.87%97.91%85.90%88.76%
Dividend Paid to FCF28.47%--36.39%

Earnings

Report DateMar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
EPS Estimate-------
EPS Actual0.090.070.050.140.020.040.04
Surprise-------
Timing-------

Key Statistics & Ratios

Market Cap6.29B
Enterprise Value5.16B
Trailing P/E61.21
Forward P/E0.00
Price / Sales16.48
Price / Book4.70
EPS0.24
Book Value3.13
Revenue (TTM)381.72M
Gross Profit (TTM)255.74M
EBITDA127.11M
Profit Margin26.97%
Operating Margin25.62%
Return on Equity7.80%
Return on Assets5.02%
Shares Outstanding428.33M
Shares Float75.13M
Dividend Yield1.02%
Dividend Rate0.15
Payout Ratio62.40%